Q1 2018 13F Holders as of 3/31/2018
-
Type / Class
-
Equity / Common Stock, no par value
-
Shares outstanding
-
15M
-
Number of holders
-
29
-
Total 13F shares, excl. options
-
5.43M
-
Shares change
-
-5.31K
-
Total reported value, excl. options
-
$36.2M
-
Value change
-
-$49.5K
-
Number of buys
-
11
-
Number of sells
-
-14
-
Price
-
$6.68
Significant Holders of CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value (CPIX) as of Q1 2018
33 filings reported holding CPIX - CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value as of Q1 2018.
CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value (CPIX) has 29 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.43M shares
of 15M outstanding shares and own 36.25% of the company stock.
Largest 10 shareholders include Stonepine Capital Management, LLC (1.32M shares), ARIEL INVESTMENTS, LLC (1.01M shares), DIMENSIONAL FUND ADVISORS LP (883K shares), RENAISSANCE TECHNOLOGIES LLC (354K shares), BlackRock Inc. (332K shares), VANGUARD GROUP INC (314K shares), BRIDGEWAY CAPITAL MANAGEMENT INC (284K shares), NEW YORK STATE COMMON RETIREMENT FUND (261K shares), JW Asset Management, LLC (179K shares), and ACADIAN ASSET MANAGEMENT LLC (107K shares).
This table shows the top 29 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.